glp 1 agonists Resmetirom and GLP-1 for MASH: complementary rather than exclusive GLP-1 Agonists in Cardiovascular Diseases:

The unique mechanism of action not only aids in glycemic control but also promotes satiety, which can lead to reduced caloric intake and support weight loss efforts, a critical component for many individuals managing type 2 diabetes

This mechanism raises a question: If GLP-1RAs impact reward pathways, can they be effectively used to treat addiction disorders

[65] [2] [80] For humans, the bioavailability from eggs is less than 9%, compared to 40% to 60% from fish, fowl, and meat

We are not criticising Melanotan itself, but we are concerned about unregulated and illegal use

Synaptogenesis: Cognitive function and cognitive enhancement: Its important to note that while Dihexa has demonstrated promising effects in preclinical studies, its safety and efficacy in humans have not been extensively studied